Painreform is trading at $0.94, up 6.78% in pre-market on October 6, 2026, with no verified catalyst identified. - Painreform closed at $0.88 on October 5. - No company announcement dated October 6 was found; the latest company updates surfaced were published earlier. - Major U.S. indexes were modestly higher, but that does not establish a reason for Painreformβs gain.